Ospraie Ag Sciences

Ospraie Ag Sciences (OAS) is a New York-based investment firm dedicated to fostering innovation within the agriculture and food technology sectors. Operating as the venture capital and private equity arm of Ospraie Management, a firm with a long-standing history in global commodity markets, OAS leverages deep industry expertise and an extensive network to identify and support disruptive technologies. The firm's core mission revolves around investing in companies that offer sustainable and efficient solutions to pressing global challenges in food production, resource management, and environmental impact. Their investment scope is broad, encompassing areas such as crop protection, biologicals, precision agriculture, supply chain optimization, animal health, and alternative proteins.

OAS primarily targets growth-stage companies, typically participating in Series A, B, and C funding rounds, though they are opportunistic across stages for compelling opportunities. They seek out businesses with proven technologies and strong management teams, providing not only capital but also strategic guidance and access to their vast industry connections. This hands-on approach aims to accelerate the development and market penetration of their portfolio companies. Their investment philosophy emphasizes long-term partnerships, focusing on companies that can deliver significant economic and environmental impact.

The firm has built a robust portfolio of leading agtech innovators. As of early 2024, Ospraie Ag Sciences has made over 25 investments, demonstrating a consistent commitment to the sector. Notable companies in their portfolio include Pairwise, a gene-editing food and agriculture company that recently closed a $100 million Series D round, and Inari, a plant breeding technology company that secured over $100 million in its Series D. These examples highlight their capacity to participate in substantial funding rounds, often contributing significant capital. While specific check sizes can vary based on the opportunity, Ospraie Ag Sciences typically deploys initial investments ranging from $5 million to $25 million, positioning them as a key partner for scaling agtech ventures.